NATERA, INC. Research and Development Expense
NATERA, INC. (NTRA) reported Research and Development Expense of $228.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- NATERA, INC. research and development expense for the quarter ending 2026-06-30 was $228.07M, a 55.76% increase year-over-year.
- NATERA, INC. research and development expense for the quarter ending 2026-03-31 was $210.70M, a 63.24% increase year-over-year.
- NATERA, INC. research and development expense for the quarter ending 2025-12-31 was $175.19M, a 35.32% increase year-over-year.
- NATERA, INC. research and development expense for the quarter ending 2025-09-30 was $173.41M, a 78.90% increase year-over-year.
- NATERA, INC. research and development expense for fiscal 2025 was $624.11M, a 54.43% increase from fiscal 2024.
- NATERA, INC. research and development expense for fiscal 2024 was $404.14M, a 26.03% increase from fiscal 2023.
- NATERA, INC. research and development expense for fiscal 2023 was $320.68M, a 1.35% increase from fiscal 2022.
- NATERA, INC. research and development expense for fiscal 2022 was $316.42M, a 19.76% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $228.07M 10-Q · filed 2026-08-07 | $438.77M 10-Q · filed 2026-08-07 | $613.97M derived: sum of 3 quarters · filed 2026-08-07 | $787.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $210.70M 10-Q · filed 2026-05-08 | $385.89M derived: sum of 2 quarters · filed 2026-05-08 | $559.31M derived: sum of 3 quarters · filed 2026-05-08 | $705.73M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $175.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $348.61M derived: sum of 2 quarters · filed 2026-02-27 | $495.03M derived: sum of 3 quarters · filed 2026-08-07 | $624.11M 10-K · filed 2026-02-27 |
| 2025-09-30 | $173.41M 10-Q · filed 2025-11-07 | $319.84M derived: sum of 2 quarters · filed 2026-08-07 | $448.92M 10-Q · filed 2025-11-07 | $578.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $146.43M 10-Q · filed 2026-08-07 | $275.50M 10-Q · filed 2026-08-07 | $404.97M derived: sum of 3 quarters · filed 2026-08-07 | $501.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $129.08M 10-Q · filed 2026-05-08 | $258.54M derived: sum of 2 quarters · filed 2026-05-08 | $355.47M derived: sum of 3 quarters · filed 2026-05-08 | $444.58M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $129.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $226.39M derived: sum of 2 quarters · filed 2026-02-27 | $315.50M derived: sum of 3 quarters · filed 2026-02-27 | $404.14M 10-K · filed 2026-02-27 |
| 2024-09-30 | $96.93M 10-Q · filed 2025-11-07 | $186.04M derived: sum of 2 quarters · filed 2025-11-07 | $274.68M 10-Q · filed 2025-11-07 | $357.64M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $89.11M 10-Q · filed 2025-08-08 | $177.75M 10-Q · filed 2025-08-08 | $260.71M derived: sum of 3 quarters · filed 2026-02-27 | $337.94M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $88.64M 10-Q · filed 2025-05-09 | $171.60M derived: sum of 2 quarters · filed 2026-02-27 | $248.84M derived: sum of 3 quarters · filed 2026-02-27 | $327.01M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $82.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $160.20M derived: sum of 2 quarters · filed 2026-02-27 | $238.37M derived: sum of 3 quarters · filed 2026-02-27 | $320.68M 10-K · filed 2026-02-27 |
| 2023-09-30 | $77.23M 10-Q · filed 2024-11-12 | $155.41M derived: sum of 2 quarters · filed 2024-11-12 | $237.71M 10-Q · filed 2024-11-12 | $325.63M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $78.17M 10-Q · filed 2024-08-09 | $160.48M 10-Q · filed 2024-08-09 | $248.39M derived: sum of 3 quarters · filed 2025-02-28 | $313.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $82.31M 10-Q · filed 2024-05-10 | $170.22M derived: sum of 2 quarters · filed 2025-02-28 | $235.73M derived: sum of 3 quarters · filed 2025-02-28 | $318.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $87.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $153.42M derived: sum of 2 quarters · filed 2025-02-28 | $236.00M derived: sum of 3 quarters · filed 2025-02-28 | $316.42M 10-K · filed 2025-02-28 |
| 2022-09-30 | $65.51M 10-Q · filed 2023-11-09 | $148.09M derived: sum of 2 quarters · filed 2023-11-09 | $228.50M 10-Q · filed 2023-11-09 | $300.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $82.58M 10-Q · filed 2023-08-04 | $162.99M 10-Q · filed 2023-08-04 | $234.81M derived: sum of 3 quarters · filed 2024-02-29 | $333.26M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $80.41M 10-Q · filed 2023-05-10 | $152.22M derived: sum of 2 quarters · filed 2024-02-29 | $250.68M derived: sum of 3 quarters · filed 2024-02-29 | $304.43M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $71.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $170.27M derived: sum of 2 quarters · filed 2024-02-29 | $224.02M derived: sum of 3 quarters · filed 2024-02-29 | $264.21M 10-K · filed 2024-02-29 |
| 2021-09-30 | $98.46M 10-Q · filed 2022-11-09 | $152.21M derived: sum of 2 quarters · filed 2022-11-09 | $192.40M 10-Q · filed 2022-11-09 | $224.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $53.75M 10-Q · filed 2022-08-05 | $93.94M 10-Q · filed 2022-08-05 | $126.32M derived: sum of 3 quarters · filed 2023-03-01 | $152.75M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $40.19M 10-Q · filed 2022-05-06 | $72.57M derived: sum of 2 quarters · filed 2023-03-01 | $98.99M derived: sum of 3 quarters · filed 2023-03-01 | $122.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $32.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $58.80M derived: sum of 2 quarters · filed 2023-03-01 | $81.81M derived: sum of 3 quarters · filed 2023-03-01 | $100.03M 10-K · filed 2023-03-01 |
| 2020-09-30 | $26.42M 10-Q · filed 2021-11-05 | $49.43M derived: sum of 2 quarters · filed 2021-11-05 | $67.65M 10-Q · filed 2021-11-05 | $82.65M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $23.00M 10-Q · filed 2021-08-06 | $41.23M 10-Q · filed 2021-08-06 | $56.23M derived: sum of 3 quarters · filed 2022-02-25 | $69.03M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $18.23M 10-Q · filed 2021-05-07 | $33.23M derived: sum of 2 quarters · filed 2022-02-25 | $46.02M derived: sum of 3 quarters · filed 2022-02-25 | $58.15M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $27.80M derived: sum of 2 quarters · filed 2022-02-25 | $39.92M derived: sum of 3 quarters · filed 2022-02-25 | $51.36M 10-K · filed 2022-02-25 |
| 2019-09-30 | $12.80M 10-Q · filed 2020-11-06 | $24.92M derived: sum of 2 quarters · filed 2020-11-06 | $36.35M 10-Q · filed 2020-11-06 | $49.13M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $12.12M 10-Q · filed 2020-08-07 | $23.56M 10-Q · filed 2020-08-07 | $36.33M derived: sum of 3 quarters · filed 2021-02-26 | $48.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $11.44M 10-Q · filed 2020-05-08 | $24.20M derived: sum of 2 quarters · filed 2021-02-26 | $36.60M derived: sum of 3 quarters · filed 2021-02-26 | $48.45M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $12.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $25.16M derived: sum of 2 quarters · filed 2021-02-26 | $37.02M derived: sum of 3 quarters · filed 2021-02-26 | $51.35M 10-K · filed 2021-02-26 |
| 2018-09-30 | $12.39M 10-Q · filed 2019-11-08 | $24.25M derived: sum of 2 quarters · filed 2019-11-08 | $38.59M 10-Q · filed 2019-11-08 | $51.60M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $11.85M 10-Q · filed 2019-08-09 | $26.19M 10-Q · filed 2019-08-09 | $39.21M derived: sum of 3 quarters · filed 2020-03-02 | $51.82M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $14.34M 10-Q · filed 2019-05-10 | $27.36M derived: sum of 2 quarters · filed 2020-03-02 | $39.97M derived: sum of 3 quarters · filed 2020-03-02 | $51.75M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $25.63M derived: sum of 2 quarters · filed 2020-03-02 | $37.41M derived: sum of 3 quarters · filed 2020-03-02 | $50.06M 10-K · filed 2020-03-02 |
| 2017-09-30 | $12.61M 10-Q · filed 2018-11-09 | $24.39M derived: sum of 2 quarters · filed 2018-11-09 | $37.05M 10-Q · filed 2018-11-09 | $48.50M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $11.79M 10-Q · filed 2018-08-09 | $24.44M 10-Q · filed 2018-08-09 | $35.90M derived: sum of 3 quarters · filed 2019-03-15 | $47.24M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $12.65M 10-Q · filed 2018-05-10 | $24.11M derived: sum of 2 quarters · filed 2019-03-15 | $35.45M derived: sum of 3 quarters · filed 2019-03-15 | $45.75M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $22.80M derived: sum of 2 quarters · filed 2019-03-15 | $33.10M derived: sum of 3 quarters · filed 2019-03-15 | $41.86M 10-K · filed 2019-03-15 |
| 2016-09-30 | $11.35M 10-Q · filed 2017-11-09 | $21.64M derived: sum of 2 quarters · filed 2017-11-09 | $30.40M 10-Q · filed 2017-11-09 | $38.41M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $10.30M 10-Q · filed 2017-08-09 | $19.06M 10-Q · filed 2017-08-09 | $27.06M derived: sum of 3 quarters · filed 2018-03-15 | $34.40M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $8.76M 10-Q · filed 2017-05-10 | $16.76M derived: sum of 2 quarters · filed 2018-03-15 | $24.10M derived: sum of 3 quarters · filed 2018-03-15 | $30.84M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $15.34M derived: sum of 2 quarters · filed 2018-03-15 | $22.08M derived: sum of 3 quarters · filed 2018-03-15 | $27.71M 10-K · filed 2018-03-15 |
| 2015-09-30 | $7.34M 10-Q · filed 2016-11-14 | $14.08M derived: sum of 2 quarters · filed 2016-11-14 | $19.71M 10-Q · filed 2016-11-14 | $24.21M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $6.74M 10-Q · filed 2016-08-11 | $12.37M 10-Q · filed 2016-08-11 | $16.87M derived: sum of 3 quarters · filed 2017-03-16 | $21.24M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $5.63M 10-Q · filed 2016-05-13 | $10.13M derived: sum of 2 quarters · filed 2017-03-16 | $14.50M derived: sum of 3 quarters · filed 2017-03-16 | $18.62M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $8.87M derived: sum of 2 quarters · filed 2017-03-16 | $12.99M derived: sum of 3 quarters · filed 2017-03-16 | $17.29M 10-K · filed 2017-03-16 |
| 2014-09-30 | $4.37M 10-Q · filed 2015-11-13 | $8.49M derived: sum of 2 quarters · filed 2015-11-13 | $12.79M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $4.12M 10-Q · filed 2015-08-13 | $8.42M 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $11.55M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |